ID

17653

Beschrijving

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part: Withdrawal of Consent

Link

https://clinicaltrials.gov/ct2/show/NCT00373425

Trefwoorden

Versies (2)
  1. 02-08-16 02-08-16 -
  2. 27-09-16 27-09-16 -
Geüploaded op

27 september 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

Engels

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulieren  
Withdrawal of Treatment Consent
Beschrijving

Withdrawal of Treatment Consent

Withdrawal of Treatment Consent: Not Applicable
Beschrijving

Withdrawal of Treatment Consent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0087111
Patient withdrew treatment consent during the study. Date:
Beschrijving

Date Consent Withdrawn

Datatype

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Withdrawal of Tissue Consent
Beschrijving

Withdrawal of Tissue Consent

Withdrawal of Tissue Consent: Not Applicable
Beschrijving

Withdrawal of Tissue Consent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0475358
Patient withdrew tumor tissue consent during the study. Date:
Beschrijving

Date Consent Withdrawn

Datatype

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Withdrawal of Optional Research Blood Sample Consent
Beschrijving

Withdrawal of Optional Research Blood Sample Consent

Withdrawal of Optional Research Blood Sample Consent: Not Applicable
Beschrijving

Withdrawal of Optional Research Blood Sample Consent

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0178913
Patient withdrew optional blood sample consent during the study. Date:
Beschrijving

Date Consent Withdrawn

Datatype

date

Alias
UMLS CUI [1,1]
C1707492
UMLS CUI [1,2]
C0011008
Investigator Signature
Beschrijving

Investigator Signature

Investigator's Signature
Beschrijving

Investigator Signature

Datatype

text

Alias
UMLS CUI [1]
C2346576
Signature Date
Beschrijving

Signature date

Datatype

date

Alias
UMLS CUI [1]
C0807937
Terug naar het begin van de pagina

Similar models

Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Withdrawal of Treatment Consent
Withdrawal of Treatment Consent
Item
Withdrawal of Treatment Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew treatment consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Withdrawal of Tissue Consent
Withdrawal of Tissue Consent
Item
Withdrawal of Tissue Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0475358 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew tumor tissue consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Withdrawal of Optional Research Blood Sample Consent
Withdrawal of Optional Research Blood Sample Consent
Item
Withdrawal of Optional Research Blood Sample Consent: Not Applicable
boolean
C0021430 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
Date Consent Withdrawn
Item
Patient withdrew optional blood sample consent during the study. Date:
date
C1707492 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item Group
Investigator Signature
Investigator Signature
Item
Investigator's Signature
text
C2346576 (UMLS CUI [1])
Signature date
Item
Signature Date
date
C0807937 (UMLS CUI [1])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial